There's a lot coming to Rainbow Six Siege in 2025. Operation Prep Phase just debuted with a new operator, but that's not all Ubisoft has up their sleeve. Siege ...

Announced during the Siege X reveal event in Atlanta, Rainbow Six Siege X Closed Beta has allowed players from around the ...

Rainbow 6: Siege has been one of the most popular multiplayer games out there for the past decade, with the game gaining a ton of momentum in the years after its launch. However, one major problem ...

The proceeds will primarily support the development of Halneuron®, a treatment for chemotherapy-induced neuropathic pain (CINP), with interim data from the Phase 2b trial anticipated in the ...

Tom Clancy’s Rainbow Six Siege was released in 2015 and has had a surprisingly long shelf-life as a live-service game. Now, coming up on its 10-year anniversary, Rainbow Six Siege is getting an ...

This is a look at the gameplay we can expect in Tom Clancy's Rainbow Six Siege Operation White Noise expansion. The map is spread out into about seven main areas as players will hunt for the ...

The Metro series has only been getting more popular over the last 15 years. Now, fans may have an idea of what comes next. Survival games are all about overcoming harsh environments and figuring ...

CALGARY, AB, March 12, 2025 /CNW/ - Horizon Petroleum Ltd. (the "Company" or "Horizon") (TSXV: HPL) (FRA: HPM) (Tradegate: HPM) is pleased to provide an operations update on progress made towards ...

The coordinated rescue operation took nearly 24 hours and ensured the safety of all passengers. The government promises to deal with all facilitators of these terrorists. Pakistan’s security ...

Image credit: Shutterstock / Sundry Photography Gilead is set to launch a Phase III trial of its once-yearly lenacapavir pre-exposure prophylaxis (PrEP) for human immunodeficiency ... licensing ...

Gilead said two ex­per­i­men­tal once-a-year ver­sions of its HIV pre­ven­tion shot lenaca­pavir passed muster in an ear­ly-stage study with a small group of healthy par­tic­i­pants … ...

Gilead, riding high from HIV sales boost, charts course for long-acting PrEP launch In the phase 1 study, the two once-yearly formulations were given to 20 individuals each. At the end of the one ...